Effects of weight loss on dynamic hyperinflation in obese women asthmatics

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER PHYSIOLOGICAL SOC
Citação
JOURNAL OF APPLIED PHYSIOLOGY, v.126, n.2, p.413-421, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Obese adults with asthma are more likely to develop dynamic hyperinflation (DH) and expiratory flow limitation (EFL) than nonobese asthmatics, and weight-loss seems to improve the breathing mechanics during exercise. However, studies evaluating the effect of weight loss on DH in obese adults with asthma have not been performed. We sought to evaluate the effect of a weight loss program on DH in obese adults with asthma. Forty-two asthma patients were enrolled in a weight loss program (diet, psychological support, and exercise) and were subsequently divided into two groups according to the percentage of weight loss: a >= 5% group (n = 19) and a <5% group (n = 23). Before and after the intervention. DH and EFL (constant load exercise), health-related quality of life (HRQoL). asthma control, quadriceps muscle strength and endurance, body composition, and lung function were assessed. Both groups exhibited a decrease of >= 10% in inspiratory capacity (DH) before intervention, and only the >= 5% group showed clinical improvement in DH compared with the <5% group postintervention (-9.1 +/- 14.5% vs. -125 +/- 13.5%, respectively). In addition, the >= 5% group displayed a significant delay in the onset of both DH and EH, and a clinically significant improvement in HRQoL and asthma control. Furthermore, a correlation was observed between reduced waist circumference and increased inspiratory capacity (r = -0.45, P = 0.05) in the >= 5% group. In conclusion, a weight-loss of >= 5% of the body weight improves DH, which is associated with waist circumference in obese adults with asthma. In addition, the group with greater weight-loss showed a delayed onset of DH and EFL during exercise and improved asthma clinical control and HRQoL. NEW & NOTEWORTHY This is the first study to evaluate dynamic hyperinflation (DH) after a weight loss program in obese patients with asthma. Our results demonstrate that moderate weight loss can improve DH in obese patients with asthma that is associated with a decrease in abdominal fat. Moreover, a minimum of 5% in weight loss delays the onset of DH and expiratory flow limitation besides inducing a clinical improvement in asthma quality of life and clinical control.
Palavras-chave
asthma, dynamic hyperinflation, expiratory flow limitation, obesity, weight loss
Referências
  1. [Anonymous], 1996, Arch Phys Med Rehabil, V77, P1251
  2. BABB TG, 1991, J APPL PHYSIOL, V70, P223
  3. Babb TG, 2011, CHEST, V140, P454, DOI 10.1378/chest.10-1088
  4. Benfante Alida, 2018, ERJ Open Res, V4, DOI 10.1183/23120541.00143-2017
  5. Bhammar DM, 2016, INT J OBESITY, V40, P998, DOI 10.1038/ijo.2016.21
  6. BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
  7. BRAY GA, 1989, MED CLIN N AM, V73, P161, DOI 10.1016/S0025-7125(16)30697-6
  8. Callens E, 2009, CHEST, V136, P1466, DOI 10.1378/chest.09-0410
  9. Coffey Michael J, 2015, J Allergy (Cairo), V2015, P157919, DOI 10.1155/2015/157919
  10. Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309
  11. de Carvalho-Pinto RM, 2012, RESP MED, V106, P47, DOI 10.1016/j.rmed.2011.08.013
  12. De Lorenzo A, 1999, RESPIRATION, V66, P407, DOI 10.1159/000029423
  13. Dias SA, 2014, EUR RESPIR J, V43, P1368, DOI 10.1183/09031936.00053413
  14. Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST
  15. Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI [10.1164/rccm.912011ST, 10.1164/rccm.9120-11ST]
  16. Ferreira PG, 2017, J APPL PHYSIOL, V123, P585, DOI 10.1152/japplphysiol.00655.2016
  17. Ferreira PG, 2016, THESIS
  18. Freitas PD, 2017, AM J RESP CRIT CARE, V195, P32, DOI 10.1164/rccm.201603-0446OC
  19. Freitas PD, 2018, MED SCI SPORT EXER, V50, P1367, DOI 10.1249/MSS.0000000000001574
  20. Gibson AL, 2008, AM J CLIN NUTR, V87, P332
  21. GINA, 2017, GLOB STRAT ASTHM MAN
  22. Global Initiative for Asthma (GINA), 2018, GIN REP GLOB STRAT A
  23. Global Initiative for Asthma (GINA), 2014, GLOBAL BURDEN ASTHMA
  24. Gordon CC, 1988, ANTHROPOMETRIC STAND
  25. Guenette JA, 2012, EUR RESPIR J, V40, P322, DOI 10.1183/09031936.00157711
  26. Hernandez Romero Azael, 2008, Rev Alerg Mex, V55, P103
  27. Hogrel JY, 2007, ARCH PHYS MED REHAB, V88, P1289, DOI 10.1016/j.apmr.2007.07.011
  28. JOHNSON BD, 1995, J APPL PHYSIOL, V79, P892
  29. JOHNSON BD, 1991, AM REV RESPIR DIS, V143, P960, DOI 10.1164/ajrccm/143.5_Pt_1.960
  30. JOHNSON BD, 1992, J APPL PHYSIOL, V73, P874
  31. Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012
  32. JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1
  33. Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x
  34. Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265
  35. JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76
  36. Leite Mylene, 2008, J. bras. pneumol., V34, P756, DOI 10.1590/S1806-37132008001000002
  37. Ma J, 2015, ANN AM THORAC SOC, V12, P1, DOI 10.1513/AnnalsATS.201406-271OC
  38. Mahadev S, 2013, PULM PHARMACOL THER, V26, P438, DOI 10.1016/j.pupt.2012.05.004
  39. Martin JG, 1993, EUR RESPIR REV, V14, P444
  40. Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
  41. Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC
  42. Neder JA, 1999, EUR RESPIR J, V14, P1304, DOI 10.1183/09031936.99.14613049
  43. Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703, DOI 10.1590/S0100-879X1999000600006
  44. O'Donnell DE, 2004, EUR RESPIR J, V23, P832, DOI 10.1183/09031936.04.00116004
  45. Ofir D, 2007, J APPL PHYSIOL, V102, P2217, DOI 10.1152/japplphysiol.00898.2006
  46. Pakhale S, 2015, CHEST, V147, P1582, DOI 10.1378/chest.14-3105
  47. Pellegrino R, 1998, CHEST, V114, P1607, DOI 10.1378/chest.114.6.1607
  48. Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008
  49. Scott HA, 2013, CLIN EXP ALLERGY, V43, P36, DOI 10.1111/cea.12004
  50. Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004
  51. Stenius-Aarniala B, 2000, BRIT MED J, V320, P827, DOI 10.1136/bmj.320.7238.827
  52. STUBBING DG, 1980, J APPL PHYSIOL, V49, P511
  53. Sutherland ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036631
  54. Villa F, 2011, ARCH DIS CHILD, V96, P554, DOI 10.1136/adc.2011.212431
  55. Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005
  56. Wasserman K, 1999, PRINCIPLES EXERCISE
  57. WOOLCOCK AJ, 1971, AM REV RESPIR DIS, V104, P703
  58. ZERAH F, 1993, CHEST, V103, P1470, DOI 10.1378/chest.103.5.1470